Human Complement Serum - May 31, 2017

Posted by Leanne Kodsman on

May 31, 2017 Innovative Research's Single Donor Human Complement Serum was recently used in the following study:

Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica

Lukmanee Tradtrantip, Xiaoming Yao, Tao Su, Alex J. Smith, Alan S. Verkman - Acta Neuropathologica, 2017 ... Complement dependent cytotoxicity Specified concentrations of AQP4-IgG (or control human IgG, Thermo Fisher Scientific, Rockford, IL) and human complement (Innovative Research, Novi, MI) were added in Hank's buffer, and cells were incubated at 37 °C for specified times. ...

Share this post


Related Posts

Identification of Receptor Ligands in Apo B100 Reveals Potential Functional Domains
Normal Single Donor Human Plasma from Innovative Research was recently used in the foll...
Read the Article

← Older Post Newer Post →